Back to Journals » Drug Design, Development and Therapy » Volume 12

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia

Total article views   HTML views PDF downloads Totals
39,495 Dovepress* 19,912+ 2,551 22,463
PubMed Central* 19,583 3,047 22,630
Totals 39,495 5,598 45,093
*Since 12 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 1 9

View citations on PubMed Central and Google Scholar